3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
2
Leukemia, Myelomonocytic, Chronic
2
Pheochromocytoma
1
Paraganglioma
1
Pancreatic Neoplasms
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gallbladder Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Paclitaxel
42
Carboplatin
37
Bevacizumab
29
liposomal doxorubicin
20
Taxes
18
Specimen Handling
18
pembrolizumab
16
olaparib
16
Magnetic Resonance Spectroscopy
16
Gemcitabine
16
Topotecan
13
Immunoglobulin G
12
Disulfides
12
Biopsy
11
niraparib
8
mirvetuximab soravtansine
8
Nivolumab
7
Doxorubicin
7
Cyclophosphamide
6
Cisplatin
6
Drug Therapy
5
130-nm albumin-bound paclitaxel
5
cemiplimab
4
cediranib
4
Letrozole
4
Injections
4
Docetaxel
4
1-dodecylpyridoxal
4
sarilumab
3
rucaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
guadecitabine
×
1 year
×
Clear all
No trials found.